Solvonis Therapeutics Plc (SVNS) ORD GBP0.001

Sell:0.16pBuy:0.17pNo change

Prices delayed by at least 15 minutes
Sell:0.16p
Buy:0.17p
Change:No change
Deal now
Prices delayed by at least 15 minutes
Sell:0.16p
Buy:0.17p
Change:No change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC, is a United Kingdom-based biotechnology company. The Company is focused on developing intellectual property related to the treatment of mental health and substance-use disorders, and co-developing therapeutics for these conditions. It focuses on improving outcomes for individuals suffering from these disorders, with an initial focus on trauma-related mental health conditions, such as PTSD. PTSD is a debilitating mental health condition characterized by persistent and distressing symptoms following exposure to traumatic events.

Key people

Anthony Tennyson
Chief Executive Officer, Executive Director
Pavel Kobzev
Chief Marketing Officer
Anthony Eastman
Company Secretary
Dennis J. Purcell
Non-Executive Chairman of the Board
Nicholas Nelson
Non-Executive Director
Renata Crome
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    SVNS
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BMD1Z199
  • Market cap
    £3.79m
  • Employees
    -
  • Shares in issue
    2.30bn
  • Exchange
    London Stock Exchange (LON)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.